Search Options Stock News and Analysis

https://www.schaeffersresearch.com/content/news/2020/09/14/3-stocks-making-major-buyout-buzz-today

9/14/2020 1:55 PM

A number of announcements regarding buyout offers for the entirety of -- or at least a large stake in -- various companies is kicking the week off at a rapid pace today. Specifically, biotech Immunome...

Option Traders Blast Gilead Sciences Stock After IMMU Deal

https://www.schaeffersresearch.com/content/news/2020/09/14/option-traders-blast-gilead-sciences-stock-after-immu-deal

9/14/2020 11:55 AM

It's been a whirlwind start to the week, with dealmaking dominating the headlines. One of the more notable is Gilead Sciences, Inc. (NASDAQ:GILD) and their acquisition of Immunomedics (IMMU) for $21 b...

IMMU Stock Keeps Climbing on Analyst Bull Note

https://www.schaeffersresearch.com/content/news/2019/12/27/immu-stock-keeps-climbing-on-analyst-bull-note

12/27/2019 9:51 AM

Immunomedics, Inc (NASDAQ:IMMU) is climbing towards another annual closing high today, up 2.3% at $22.16, after H.C. Wainwright lifted its price target to $31 from $26. This bull note come right on th...

Signal Says Drug Stock Not Done Climbing

https://www.schaeffersresearch.com/content/analysis/2019/12/10/signal-says-drug-stock-not-done-climbing

12/10/2019 2:30 PM

It's been a hot start to December for Immunomedics, Inc. (NASDAQ:IMMU). The pharmaceutical stock is up 11.5% already this month, and earlier today nabbed a fresh annual high of $21.49. Heading into t...

Call Traders Eye Biotech Stock's Big Drop

https://www.schaeffersresearch.com/content/options/2019/09/30/call-traders-eye-biotech-stocks-big-drop

9/30/2019 11:56 AM

One of the worst stocks on the Nasdaq today is Immunomedics, Inc. (NASDAQ:IMMU), after the company said it was delaying the submission of its application for Food and Drug Administration (FDA) approv...

PEOPLE ALSO SEARCH FOR